Medicine

Fuatilia
Medical researchers at University of Calgary reviewing glioblastoma scans alongside niacin supplements for a clinical trial illustration.
Picha iliyoundwa na AI

Early University of Calgary trial tests high-dose niacin as add-on treatment for glioblastoma

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

Researchers at the University of Calgary are studying whether high doses of vitamin B3 (niacin) can improve outcomes for patients with newly diagnosed glioblastoma when added to standard treatment. An interim analysis of 24 patients found a higher-than-expected six‑month progression‑free survival rate, though investigators stress the results are preliminary and require ongoing safety monitoring.

A Newcastle University-led screening study of nearly 300 adults in northern Britain found persistently high rates of low vitamin D in older people and adults from minoritized ethnic groups, with little evidence that summer months substantially improved levels.

Imeripotiwa na AI

New research indicates that oestrogen levels, which vary across the menstrual cycle, can influence how efficiently some drugs reach the brain in women.

Two existing medications cooled core body temperature in animals after stroke and reduced brain damage. A small human trial showed limited effect due to slow delivery. Researchers are now planning a follow-up study with faster infusions.

Imeripotiwa na AI

Researchers at Texas A&M University have shown that mammals may possess dormant abilities to regrow complex body parts. A new two-step treatment redirected healing in mice away from scarring toward tissue regeneration. The approach restored bone, joints, ligaments and tendons after amputation.

Adults with obesity who began taking GLP-1 receptor agonist medications showed declines in Fitbit-measured physical activity after starting treatment, according to a retrospective study presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago.

Imeripotiwa na AI

Researchers have discovered that mutations in the CD99L2 gene cause X-linked spastic ataxia, a rare movement disorder. The finding came from analysis of 2,811 patients with conditions affecting coordination and muscle control. The study was published in Nature Communications.

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa